Knigth's Move in the Periodic Table, From Copper to Platinum, Novel Antitumor Mixed Chelate Copper Compounds, Casiopeinas, Evaluated by an in Vitro Human and Murine Cancer Cell Line Panel

We synthesized a novel anticancer agents based on mixed chelate copper (II) complexes, named Casiopeínas® has of general formula [Cu(N-N)(N-O)H2O]NO3 (where, N-N = diimines as 1,10- phenanthroline, 2,2-bipyridine, or substituted and N-O=aminoeidate or [Cu(N-N)(O-O)H2O]NO3 (where NN= diimines as 10-phenanthroline, 2,2-bipyridine or substituted Casiopeínas I, II, IV, V, VI, VII VIII and O-O=acetylacetonate, salicylaldehidate Casiopínas III). We evaluated the in vitro antitumor activity using a human cancer cell panel and some nurine cancer cells. Eleven Casiopeinas are evaluated in order to acquire some structure-activity correlations and some monodentated Casiopeinäs analogues; cisplatinum was used as control drug. The 50% growth inhibition observed is, in all cases reach with concentrations of Casiopeina's 10 or 100 times lower than cisplatinum. In a previous work we reported the induction of apoptosis by Casiopeina II. The results indicate that Casiopeinass are a promising new anticancer drug candidates to be developed further toward clinical trials.

• Publication year

  2001

• Venue

  Metal-Based Drugs

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1155/MBD.2001.19PMID 18475972PMCID 2365248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells.

  2000cited by this paper
• Ternary copper complexes and manganese (III) tetrakis(4-benzoic acid) porphyrin catalyze peroxynitrite-dependent nitration of aromatics.

  1997cited by this paper
• Aqua(1,10-phenanthroline)(l-serinato)copper(II) Nitrate

  1995cited by this paper
• Cytostatic, mutagenic, antineoplastic activities and preliminar toxicity of copper (II) new drugs: Casiopeinas I, II, III.

  1993cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS

  1972cited by this paper

• Recent advances in the study of cuproptosis in gliomas.

  2025cites this paper
• Harnessing redox reactions for anticancer effects: A copper(II) Schiff base complex induces apoptosis in HepG2 liver cancer cells via ROS generation.

  2025cites this paper
• Copper(II) complex with 1-allylimidazole induces G2/M cell cycle arrest and suppresses A549 cancer cell growth by attenuating Wnt, JAK-STAT, and TGF-β signaling pathways.

  2024cites this paper
• Antiproliferative activity of platinum(II) and copper(II) complexes containing novel biquinoxaline ligands

  2024cites this paper
• Antitumoral and Antimetastatic Activity by Mixed Chelate Copper(II) Compounds (Casiopeínas®) on Triple-Negative Breast Cancer, In Vitro and In Vivo Models

  2024cites this paper
• The Bulk Breast Cancer Cell and Breast Cancer Stem Cell Activity of Binuclear Copper(II)‐Phenanthroline Complexes

  2023cites this paper
• Recent Development of Copper (II) Complexes of Polypyridyl Ligands in Chemotherapy and Photodynamic Therapy

  2023cites this paper
• D,L-Citrullinato-bipyridine Copper Complex: Experimental and Theoretical Characterization

  2023cites this paper
• A bioinspired redox-modulating copper(II)-macrocyclic complex bearing non-steroidal anti-inflammatory drugs with anti-cancer stem cell activity.

  2022cites this paper
• DNA, a target of mixed chelate copper(II) compounds (Casiopeinas®) studied by electrophoresis, UV-vis and circular dichroism techniques.

  2022cites this paper
• Anticancer Investigation of Platinum and Copper-Based Complexes Containing Quinoxaline Ligands

  2021cites this paper
• Theoretical determination of half-wave potentials for phenanthroline-, bipyridine-, acetylacetonate-, and glycinate-containing copper (II) complexes

  2020cites this paper
• Copper(II):phenanthroline complexes with l-asparagine and l-methionine: Synthesis, crystal structure and in-vitro cytotoxic effects on prostate, breast and melanoma cancer cells

  2020cites this paper
• Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix

  2020cites this paper
• Development, evaluation and effect of anionic co-ligand on the biological activity of benzothiazole derived copper(II) complexes.

  2020cites this paper
• Copper(I) complexes with phosphines P(p-OCH3-Ph)2CH2OH and P(p-OCH3-Ph)2CH2SarGly. Synthesis, multimodal DNA interactions, and prooxidative and in vitro antiproliferative activity.

  2019cites this paper
• Antiproliferative activity of copper(II) glutamine complexes with N,N-donor ligands: Synthesis, characterization, potentiometric studies and DNA/BSA interactions

  2019cites this paper
• Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells

  2018cites this paper
• Structural Diversity, Electrochemical, and DNA-Binding Properties of Copper(II) Carboxylates

  2018cites this paper
• Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia.

  2017cites this paper
• X-Ray Crystallographic Analysis, EPR Studies, and Computational Calculations of a Cu(II) Tetramic Acid Complex

  2017cites this paper
• Genotoxicity of Casiopeina III-Ea in mouse bone marrow cells

  2017cites this paper
• Evaluation of the binding of four anti-tumor Casiopeínas® to human serum albumin.

  2017cites this paper
• In vitro DNA damage by Casiopeina II-gly in human blood cells

  2016cites this paper
• Effect of [Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)]NO3, Casiopeína III-Ea, on the activity of cytochrome P450.

  2016cites this paper
• Structural Diversity, Electrochemical, and DNA-Binding Properties of Copper(II) Carboxylates

  2016cites this paper
• Magnetic property, DFT calculation, and biological activity of bis[(μ(2)-chloro)chloro(1,10-phenanthroline)copper(II)] complex.

  2015cites this paper
• Crystal structures and antimicrobial and cytotoxic activities of zinc(II), nickel(II) and copper(II) complexes of N-(piperidylthiocarbonyl)benzamide

  2015cites this paper
• DNA-binding mode of antitumoral copper compounds (Casiopeinas®) and analysis of its biological meaning

  2015cites this paper
• Organo-Metallic Compounds: Novel Molecules in Cancer Therapy

  2014cites this paper
• Synthesis, crystal structure description, electrochemical, and DNA-binding studies of “paddlewheel” copper(II) carboxylate

  2014cites this paper
• Thione- and Selone-containing Compounds, Their Late First Row Transition Metal Coordination Chemistry, and Their Biological Potential

  2014cites this paper
• Cytotoxicity towards human alimentary system carcinoma cells resulting from diverse copper(II) complexes

  2014cites this paper
• Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.

  2014cites this paper
• A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity

  2013cites this paper
• Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(II) complex against human cervical cancer.

  2013cites this paper
• Mixed-ligand Cu(II)-vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity.

  2013cites this paper
• Analysis of Apoptotic and Autophagic Pathways in Neuroblastoma by Treatment with Copper Compounds

  2013cites this paper
• ytotoxic , pro-apoptotic , pro-oxidant , and non-genotoxic activities of novel copper ( II ) complex against human cervical cancer

  2013cites this paper
• Identification of [CuCl(acac)(tmed)], a copper(II) complex with mixed ligands, as a modulator of Cu,Zn superoxide dismutase (Sod1p) activity in yeast

  2012cites this paper
• New achievements on biological aspects of copper complexes Casiopeínas®: interaction with DNA and proteins and anti-Trypanosoma cruzi activity.

  2012cites this paper
• Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation

  2012cites this paper
• Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.

  2012cites this paper
• Copper(II) and Palladium(II) Complexes with Cytotoxic and Antibacterial Activity

  2012cites this paper
• Synthesis, structural characterization and microbial activities of mixed ligand copper(II) complexes of 2,2′-bipyridine and acetylacetonate

  2011cites this paper
• Biological activity and structure dependent properties of cuprous iodide complexes with phenanthrolines and water soluble tris (aminomethyl) phosphanes.

  2011cites this paper
• Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.

  2011cites this paper
• Genotoxicity of the copper antineoplastic coordination complexes casiopeinas.

  2011cites this paper
• Characterization of physical interaction between Casiopeina III-ia and chitosan. Toward a Cas III-ia drug delivery system.

  2011cites this paper
• Synthesis, structural characterization, formation constants and in vitro cytotoxicity of phenanthroline and imidazolidine-2-thione copper(II) complexes.

  2011cites this paper
• Synthesis, Crystal Structure and DNA Cleavage Activity of a Ternary Copper(II) Complex of Dipyrido[3,2‐d:2′,3′‐f]‐quinoxaline and Glycine

  2011cites this paper
• Novel copper(II) heterochelate: synthesis, structural features and fluorescence studies

  2010cites this paper
• Synthesis, characterization, cytotoxic activities, and DNA-binding studies of ternary copper(II) complexes with new coumarin derivatives.

  2010cites this paper
• Pharmacokinetics of Casiopeína IIgly in Beagle Dog: A Copper Based Compound with Antineoplastic Activity

  2010cites this paper
• Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N-N)(acetylacetonato)]NO3 and [Cu(N-N)(glycinato)]NO3 complexes, (Casiopeínas).

  2009cites this paper
• Metals in Medicine: Therapeutic Agents

  2009cites this paper
• Copper(II) complexes of tridentate SNO ligands: synthesis, characterization and crystal structure

  2009cites this paper
• Copper complexes as anticancer agents.

  2009cites this paper
• Targeting of cancer energy metabolism.

  2009influential citation
• Ternary copper(II) complex of 1,10-phenanthroline and L-glycine: crystal structure and interaction with DNA

  2008cites this paper
• An integrated experimental and theoretical investigation of the vibrational modes and molecular structure of a new Cu(II)–phosphocreatine complex

  2008cites this paper
• Synthesis, structure and spectral studies on mixed ligand copper(II) complexes of diimines and acetylacetonate

  2008cites this paper
• Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo

  2008cites this paper
• Synthesis, structure and biological activities of cobalt(II) and zinc(II) coordination compounds with 2-benzimidazole derivatives.

  2008cites this paper
• Casiopeína IIgly induced cytotoxicity to HeLa cells depletes the levels of reduced glutathione and is prevented by dimethyl sulfoxide.

  2008cites this paper
• Energy metabolism in tumor cells

  2007cites this paper
• Synthesis and structure of novel copper(II) complexes with pyrazole derived ligands and metal–ligand interaction in solution

  2007cites this paper
• Assessment of acute respiratory and cardiovascular toxicity of casiopeinas in anaesthetized dogs.

  2007cites this paper
• Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.

  2007cites this paper
• Mixed chelate copper complex, Casiopeina IIgly, binds and degrades nucleic acids: a mechanism of cytotoxicity.

  2007cites this paper
• Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)

  2007cites this paper
• Cardiotoxicity of copper-based antineoplastic drugs casiopeinas is related to inhibition of energy metabolism.

  2006cites this paper
• Cas IIgly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms.

  2005cites this paper
• Structural and reactivity studies on 4,4'-dimethyl-2,2'-bipyridine acetylacetonate copper(II) nitrate (CASIOPEINA III-ia®) with methionine, by UV-visible and EPR techniques

  2004cites this paper
• A novel cytotoxic ternary copper(II) complex of 1,10-phenanthroline and L-threonine with DNA nuclease activity.

  2004cites this paper
• Toxic effects of copper-based antineoplastic drugs (Casiopeinas) on mitochondrial functions.

  2003cites this paper
• Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II.

  2003cites this paper
• Development and validation of a liquid chromatographic method for Casiopeina IIgly in rat plasma.

  2002cites this paper
• Development and validation of a liquid chromatographic method for Casiopeina IIIi in rat plasma.

  2002cites this paper